|
CN111925283A
|
|
Preparation method of dapagliflozin impurity
|
|
CN111925289A
|
|
Preparation method of 5-bromo-2-chlorobenzoic acid
|
|
CN112010851A
|
|
Preparation method of moxifloxacin hydrochloride
|
|
CN112028754A
|
|
Preparation method of safinamide mesylate intermediate
|
|
CN111440149A
|
|
Preparation method of dabigatran etexilate intermediate
|
|
CN110078640A
|
|
A kind of synthetic method of Valsartan intermediate
|
|
CN107987074A
|
|
A kind of synthetic method of Pradofloxacin
|
|
CN107936006A
|
|
A kind of synthetic method of razaxaban
|
|
CN107382875A
|
|
A kind of synthetic method of rosuvastain calcium chiral isomer impurity
|
|
CN107298675A
|
|
A kind of preparation method of rosuvastain calcium intermediate
|
|
CN107445992A
|
|
A kind of synthetic method of Rosuvastatin Calcium intermediate
|
|
CN106866560A
|
|
A kind of synthetic method of Lesinurad
|
|
CN106748850A
|
|
A kind of preparation method of Pregabalin
|
|
CN106632090A
|
|
Method for preparing erlotinib hydrochloride by one step
|
|
CN106632223A
|
|
2-(3-bromine-4-(3-fluorobenzyloxy)phenyl)-1,3-dioxolame and preparation method thereof
|
|
CN106565521A
|
|
Method for preparing (S)-2-[3-(3-fluorobenzyl)-4-(3-fluorobenzyloxy)benzylamino]propionamide and salts thereof
|
|
CN106565442A
|
|
Preparation method of 3-(3-luorobenzyl)-4-(3-fluorobenzyloxy)benzaldehyde
|
|
CN106349269A
|
|
2-(3-fluorobenzyloxy)-5-formylphenylboronic acid and preparation method thereof
|
|
CN105753765A
|
|
Preparation method of ziprasidone intermediate
|
|
CN105503726A
|
|
Preparation method of ivabradine hydrochloride crystal form variant DELTA-D
|
